Skip to main content

Advertisement

Log in

Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The highly malignant/metastatic murine large cell lymphoma cell line RAW117-H10 forms 100–200 times more liver metastatic tumors than its parental counterpart cell line RAW117-P. RAW117-H10 cells, but not the less malignant/metastatic parental cells, significantly inhibited the mitogen-induced proliferation of normal syngeneic Balb/c and allogeneic ICRC mouse spleen cells. Such an inhibition also occurred when mitomycin-C treated metastatic lymphoma cells were added 24 h after initiation of culture, indicating that no competition with mitogen binding sites on the lymphocytes was necssary for inhibition of proliferation. ‘Antiproliferative’ cell surface molecules were extracted non-cytolytically from the RAW117-H10 cells using butanol. The butanol extracts from the metastatic RAW117-H10 cells also inhibited the mitogen-induced proliferation and natural killer (NK) cell-mediated cytotoxicity of normal spleen cells. Our results indicate that these ‘antiproliferative’ cell surface molecules of metastatic murine RAW117-H10 lymphoma cells may have important role(s) in tumor-mediated host immunosuppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bast, J. C., 1985, Principles of cancer biology: tumor immunology.Cancer, Principles and Practice of Oncology, edited by V. DeVita, S. Hellman and S. Rosenberg (Philadelphia: Lippincott), pp. 125–150.

    Google Scholar 

  2. Brunson, K. W., andNicolson, G. L., 1978, Selection and biologic properties of malignant variants of a murine lymphosarcoma.Journal of the National Cancer Institute,61, 1499–1503.

    PubMed  Google Scholar 

  3. Brunson, K. W., andGoldfarb, R. H., 1989, Immunosuppression by metastatic tumors.Influence of the Host on Tumor Development, edited by R. B. Herberman, (Dordrecht: Kluwer), pp. 133–138.

    Google Scholar 

  4. Ciancialo, G. J., Kipnis, R. J., andSnyderman, R., 1984, Similarity between p15E of murine and feline leukemia viruses and p21 of HTLV.Nature,311, 515–517.

    Google Scholar 

  5. Ciancialo, G. J., Copeland, T. D., Oroszlan, S., andSnyderman, R., 1985, Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.Science,230, 453–455.

    PubMed  Google Scholar 

  6. Cochran, A. J., Phil, E., Wen, D. R., Hoon, D. S. B., andKorn, E. L., 1987, Zoned immune suppression of lymph nodes draining malignant melanoma: Histologic and immunohistologic studies,Journal of the National Cancer Institute,78, 399–405.

    PubMed  Google Scholar 

  7. Ebert, E. C., Roberts, A. I., Connel, S. M., Robertson, F. M., andHideaki, N., 1987, Characterization of an immunosuppressive factor derived from colon cancer cells,Journal of Immunology,138, 2161–2168.

    Google Scholar 

  8. Fujii, T., Igarashi, T., andKishimoto, S., 1987, Significance of suppressor macro-phages for immunosurveillance of tumor-bearing mice.Journal of the National Cancer Institute,78, 509–517.

    PubMed  Google Scholar 

  9. Flawrylko, E., 1978, Mechanisms by which tumor cells escape immune destruction.The Handbook of Cancer Immunology, vol. 2, edited by H. Waters (Garland: STPM Press), pp. 1–18.

    Google Scholar 

  10. Joshi, S. S., Sharp, J. G., andBrunson, K. W., 1987, Differential growth characteristics of low and high metastatic variant RAW117 murine lymphosarcoma cells.Onocology,44, 180–185.

    Google Scholar 

  11. Joshi, S. S., Sharp, J. G., Gharpure, H. M., andBrunson, K. W., 1987, Characterization of metastasis associated antigens on metastatic variant RAW117 lymphosarcoma cell lines,Clinical and Experimental Metastasis,5, 89–103.

    PubMed  Google Scholar 

  12. Joshi, S. S., Tilden, P. A., Jackson, J. D., Sharp, J. G., andBrunson, K. W., 1987, Cell surface properties associated with malignancy of metastatic large cell lymphoma cells,Cancer Research,47, 3551–3557.

    Google Scholar 

  13. Joshi, S. S., Mathews, N. B., Sinangil, F., Volsky, D. J., Sharp, J. G., andBrunson, K. W., 1988, Effects of differentiation inducing chemicals onin vivo malignancy and NK susceptibility of metastatic lymphoma cells,Cancer Detection and Prevention,11, 405–417.

    PubMed  Google Scholar 

  14. Joshi, S. S., Jackson, J. D., andSharp, J. G., 1985, Differentiation inducing effects of butyrate and DMSO on human intestinal tumor cell lines.Cancer Detection and Prevention,8, 237–245.

    PubMed  Google Scholar 

  15. Joshi, S. S., andMcDonald, T. L., 1988, Immunoregulation by metastatic lymphoma cells and their cell surface molecules.Experimental Hemotology,16, 534.

    Google Scholar 

  16. Ladisch, S., Gillary, B., Clifford, W., andUlsh, L., 1983, Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides.Cancer Research,43, 3808–3813.

    PubMed  Google Scholar 

  17. Laemmli, U. K., 1970, Cleavage of structured proteins during the assembly of the head of bacteriophage T4.Nature,277, 680–685.

    Google Scholar 

  18. LeGrue, S. J., 1982, 1-Butanol extraction and subsequent reconstitution of membrane components which mediate metastatic phenotype.Cancer Research,42, 2126–2134.

    PubMed  Google Scholar 

  19. LeGrue, S. J., andHearn, D. R., 1983, Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.Cancer Research,43, 5106–5111.

    PubMed  Google Scholar 

  20. LeGrue, S. J., Pellis, N. R., Riley, L. B., andKhan, B. D., 1985, Biochemical characterization of 1-butanol extracted murine tumor-specific transplantation antigens.Cancer Research,45, 3164–3172.

    PubMed  Google Scholar 

  21. Keren, Z., Leland, F., Nakajima, M., andLeGrue, S. J., 1989, Inhibition of experimental metastasis and extracellular matrix degradation by butanol extracts from B16-F1 murine melanoma.Cancer Research,4, 295–300.

    Google Scholar 

  22. LeGrue, S. J., 1985, Noncytolytic extraction of cell surface antigens using butanol.Cancer and Metastasis Reveiws,4, 209–219.

    Google Scholar 

  23. Lovett, E. J., Dickinson, R. W., andVarani, J., 1982, Metastatic variants from a methyl cholanthrane induced syngeneic murine fibrosarcoma produce immunosuppression proportional to the metastatic potential of the variant.Tumor Progression and Markers, edited by C. K. Lapis, A. Jenny and M. R. Price (Amsterdam: Kugler), pp. 145–153.

    Google Scholar 

  24. Nicolson, G. L., 1987, Tumor cell instability, diversification, and progression to metastatic phenotype: from oncogenes to oncofetal expression.Cancer Research,47, 1473–1487.

    PubMed  Google Scholar 

  25. Nicolson, G. L., LaBiche, R. A., Frazier, M. L., Blick, M., Tressler, R. J., Reading, C. L., Irimura, T., andRotter, V., 1986, Differential expression of metastasis-associated cell surface glycoproteins and mRNA in a murine large cell lymphoma.Journal of Cellular Biochemistry,24, 95–102.

    Google Scholar 

  26. Poss, M. L., Mullins, J. I., andHoover, E. A., 1989, Post translational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.Journal of Virology,63, 189–195.

    PubMed  Google Scholar 

  27. Reading, C. L., Kraemer, P. M., Miner, K. M., andNicolson, G. L., 1983,In vivo andin vitro properties of malignant variants of RAW117 metastatic murine lymphoma/lymphosarcoma.Clinical and Experimental Metastasis,1, 135–153.

    PubMed  Google Scholar 

  28. Reading, C. L., Brunson, K. W., Torianni, M., andNicolson, G. L., 1980, Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glyoprotein gp70.Proceedings of the National Academy of Sciences, U.S.A.,77, 5943–5967.

    Google Scholar 

  29. Schirrmacher, V., 1985, Cancer metastasis; experimental approaches, theoretical concepts, and impacts for treatment strategies.Advances in Cancer Research, edited by G. Klein and S. Weinhouse (New York: Academic Press), vol. 43, pp. 1–60.

    Google Scholar 

  30. Snyderman, R., andCiancialo, G. J., 1984, Immunosuppressive activity of the retroviral envelope protein P15E and its possible relationship to neoplasia.Immunology Today,5, 240–243.

    Google Scholar 

  31. Wiltrout, R. H., Herberman, R. B., Zhang, S., Chirigos, M. A., Ortaldo, J. R., Green, K. M., andTalmadge, J. E., 1985, Role of organ associated NK cells in decreased formation of experimental metastases in lung and liver.Journal of Immunology,134, 4267–4275.

    Google Scholar 

  32. Wiltrout, R. H., Mathieson, B. J., Talmadge, J. E., Reynolds, C. W., Zhang, S.-R., Herberman, R. B., andOrtaldo, R., 1984, Augmentation of organ-associated NK acitivity by biological response modifiers: isolation and characterization of large granular lymphocytes from the liver.Journal of Experimental Medicine,160, 1431–1442.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joshi, S.S., O'connor, S.J., Weisenburger, D.D. et al. Enhanced antiproliferative activity by metastatic RAW117 lymphoma cells. Clin Exp Metast 9, 27–37 (1991). https://doi.org/10.1007/BF01831707

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01831707

Keywords

Navigation